Dope Entrepreneurs
  • Research
  • News
  • Interviews
  • Articles
  • Reviews
No Result
View All Result
  • Research
  • News
  • Interviews
  • Articles
  • Reviews
No Result
View All Result
Dope Entrepreneurs
No Result
View All Result
Home Research

The Battle Against Irritable Bowel Syndrome (IBS)

IBS sufferers struggle more than ever to manage symptoms.

hplictawa@gmail.com' by Editorial Team
May 7, 2022
in Research
2
The Battle Against Irritable Bowel Syndrome (IBS)
2.8k
SHARES
6.3k
VIEWS
Share on FacebookShare on TwitterShare On Whatsapp

Medically reviewed by Onikepe Adegbola, MD, PhD

Irritable Bowel Syndrome

The majority of IBS sufferers polled believe that managing their symptoms has gotten more difficult in the last year.

ADVERTISEMENT

Bausch Health Company Inc. and Salix Pharmaceuticals have published report findings that may help improve IBS patients.

Irritable bowel syndrome (IBS) mainly affects your large intestine. You may experience cramps, stomach pain, bloating, gas, or both diarrhea and constipation. Like most chronic conditions, IBS  needs long-term disease management. As one of the world’s largest specialty pharmaceutical companies, Bausch Health Company Inc.

(Bausch Health) and Salix Pharmaceuticals (Salix) make major contributions to gastrointestinal illness and disorder prevention and treatment. The findings of the second edition of their Patient Perspectives Survey were announced. Adults with chronic idiopathic constipation (CIC) or irritable bowel syndrome were enrolled in this study (IBS).

How Did They Conduct The Survey?

Fairleigh Dickinson University’s FDU Poll surveyed non-probability online samples of U.S. residents in February 2022. The sample was drawn from people who had previously reported gastrointestinal issues. Only those who self-reported constipation, chronic constipation, or diarrhea were included in the sample of 728 people who took part in the study.  For the study, a panel of U.S. citizens was chosen, and respondents were given $5.00 for their time. 

Because of the survey’s limitations, the results may not be typical of the broader community of persons with IBS or CIC.

What Does The Report Include?

The report explores the behaviors of patients suffering from IBS and CIC over the past year from Feb 2021 to Feb 2022. It includes insights on diagnosis and symptom management. Almost half of the respondents (49%) said their IBS symptoms had become more difficult to control in the previous year. The COVID-19 pandemic might be a crucial factor in the difficult IBS treatment. According to researchers, the pandemic harmed the whole healthcare system and impacted the lives of those with chronic illnesses. 

Furthermore, the paper covers symptom management and reporting inadequacies, as well as treatment impediments. They examined the Patient-provider communications in the survey.

Both the industries aim to provide patients and healthcare providers with valuable information sources and address the needs of the entire IBS and CIC community.

New Findings In The Report

The report mentions that the majority of patients reported experiencing symptoms of IBS or CIC within the past 24 months. According to the survey, more than three out of four patients have experienced no improvement or worsening of several symptoms of IBS or CIC over the last 12 months (between 77% and 81%).

It reveals that nearly 90% of patients diagnosed with IBS or CIC by their health care provider were initially diagnosed during an in-person visit while the majority of patients prefer to communicate with the health care provider in person.

Furthermore, nearly 40% of patients stated that they only reported their major IBS or CIC-related symptoms to their doctor, rather than all of their symptoms. 

Finally, when IBS or CIC was identified, over one-third of patients were not provided a prescription drug to address their symptoms.

Key Takeaway

To help improve clinical outcomes, this year’s report highlights the need for more meaningful provider visits. This report will help in smooth communication in the future. However, the data are not precise due to the survey limitations. The report’s findings are influenced by the pandemic and collapsed healthcare system. A detailed survey should be carried out next year for a better understanding.

Reference:

MultiVu. (n.d.). Half of IBS patients surveyed report IBS symptoms more challenging to manage in the past year. MultiVu. Retrieved May 3, 2022, from https://www.multivu.com/players/English/9017851-salix-pharmaceuticals-survey-living-with-ibs-now/

Tags: CICIBSsurvey
hplictawa@gmail.com'

Editorial Team

Related Posts

Clinical Study Supports North Atlantic Consensus Recommendations For Diagnosing SIBO & Carbohydrate Malabsorption Via Breath Testing
Research

Clinical Study Supports North Atlantic Consensus Recommendations For Diagnosing SIBO & Carbohydrate Malabsorption Via Breath Testing

May 17, 2022
French Real-World Study Upholds Benefits Of Bifidobacterium longum 35624 In Severe IBS
Research

French Real-World Study Upholds Benefits Of Bifidobacterium longum 35624 In Severe IBS

May 17, 2022
Study Shows IBD Patients Have Altered Gut Microbe Composition Even in Remission Phase
Research

Study Shows IBD Patients Have Altered Gut Microbe Composition Even In Remission Phase

May 17, 2022
Next Post
The Nutrition Connection With Neurologic And Psychiatric Health

The Nutrition Connection With Neurologic And Psychiatric Health

Risk Of Lymphoma Low In Japanese With IBD On Thiopurine Therapy

Risk Of Lymphoma Low In Japanese With IBD On Thiopurine Therapy

How The Gut Microbiome Influences What You Eat

How The Gut Microbiome Influences What You Eat

Comments 2

  1. Pingback: You Probably Don't Have IBS — Why Is That? - Dope Entrepreneurs
  2. Pingback: “IBS Patients Are Willing To Accept Significant Risks In Return For Cure Of IBS Symptoms” – A Recent UK Study - Dope Entrepreneurs

Follow Us

  • 9.4k Followers

Recommended

The Inspiring story of young Indian Entrepreneur Mrinal Mishra

1 year ago
Kite365: The Rise of Self-made Young Entrepreneur Mohayudeen Lakhani

Kite365: The Rise of Self-made Young Entrepreneur Mohayudeen Lakhani

1 year ago
With 4,01,000 new permanent residents, Canada meets its immigration target for 2021.

With 4,01,000 new permanent residents, Canada meets its immigration target for 2021.

5 months ago
Former President Park Geun-hye, who was imprisoned for corruption, will be granted a special pardon by South Korea.

Former President Park Geun-hye, who was imprisoned for corruption, will be granted a special pardon by South Korea.

5 months ago

Instagram

    Go to the Customizer > JNews : Social, Like & View > Instagram Feed Setting, to connect your Instagram account.

Categories

  • General
  • News
  • Research

Topics

antibiotics capsaicin COVID Crohn's Disease Finocontrol FODMAP german ambulance german news gluten-free Gopal Khilwani gut gut bacteria gut microbiome gut microbiota Harsh Sharma Harsh Sharma Max health healthy diet IBD IBS IBS diet inflammation inflammatory bowel disease irritable bowel syndrome Jaora Karishma Kar Liran Mizrahi low FODMAP diet Max microbiota Omicron pension peppermint oil Priyanshu Behera probiotics prototype lickable TV screen russian pension SIBO sports Taste the TV (TTTV) Tiktok treatment ukraine news United States Yash Shukla
No Result
View All Result
https://casadesante.com https://casadesante.com https://casadesante.com

Highlights

Study Identifies Cross-talks Between Dietary Fiber, Gut Microbes, & Chronic Inflammation

Antibiotics May Alter Gut Microbiome And Play A Role In IBS

Sucrase-isomaltase Gene Deficiency May Be Mistaken For IBS

COVID-19 May Increase Your Risk For IBS And Other Functional GI Disorders

The Low FODMAP Diet Is Effective In Reducing The Symptoms Of Irritable Bowel Syndrome

Supplementation Of Propolis – A Honeybee Product – Shows Promise In IBS Treatment

Trending

Clinical Study Supports North Atlantic Consensus Recommendations For Diagnosing SIBO & Carbohydrate Malabsorption Via Breath Testing
Research

Clinical Study Supports North Atlantic Consensus Recommendations For Diagnosing SIBO & Carbohydrate Malabsorption Via Breath Testing

by Editorial Team
May 17, 2022
0

Medically reviewed by Onikepe Adegbola, MD, PhD  Image by Julien Tromeur from Unsplash A recent clinical study...

French Real-World Study Upholds Benefits Of Bifidobacterium longum 35624 In Severe IBS

French Real-World Study Upholds Benefits Of Bifidobacterium longum 35624 In Severe IBS

May 17, 2022
Study Shows IBD Patients Have Altered Gut Microbe Composition Even in Remission Phase

Study Shows IBD Patients Have Altered Gut Microbe Composition Even In Remission Phase

May 17, 2022
Study Identifies Cross-talks Between Dietary Fiber, Gut Microbes, & Chronic Inflammation (1200 × 628 px)

Study Identifies Cross-talks Between Dietary Fiber, Gut Microbes, & Chronic Inflammation

May 17, 2022
Antibiotics May Alter Gut Microbiome and Play a Role in IBS

Antibiotics May Alter Gut Microbiome And Play A Role In IBS

May 11, 2022
Dope Entrepreneurs

Dope Entrepreneurs is the hub for all dope gut health related content. We are a groundbreaking news publication dedicated to gut health. We cover gut health research, entrepreneurship, startups and the latest trends in gut health. We serve a growing segment of patients, entrepreneurs and investors who want to learn more about gut health, the disruption and market potential in this field, and how they can benefit from the latest advances in gut health. Dope entrepreneurs is led by Onikepe Adegbola, MD PhD DipIBLM, physician, scientist, and gut health entrepreneur.

Categories

  • Research
  • News
  • Articles
  • Reviews
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms And Conditions


© 2022 Dope Entrepreneurs

No Result
View All Result
  • Research
  • News
  • Interviews
  • Articles
  • Reviews

© 2022 Dope Entrepreneurs

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist